Application of flow cytometry immunophenotyping and multidrug
resistance assay in B-cell acute lymphoid leukemia and multiple
myeloma
(36 — 42)
K., JAKAB, L., GOPCSA, E., ADAM, G., DOMJAN, B., SARKADI, K., PALOCZI,
Comparison of the serum erythropoietin levels in chemotherapy-
naive and cisplatin-treated cancer patients
(43 — 45)
M., ARSLAN, T., EVRENSEL, E., KURT, M., DEMIRAY, I., ERCAN, O., KANAT, A., OZKAN, O., MANAVOGLU,
No evidence of HTLV-I infection in patients with mycosis fungoides
and Sezary syndrome
(52 — 55)
M., PAWLACZYK, V., FILAS, M., SOBIESKA, A., GOZDZICKA-JOZEFIAK, K., WIKTOROWICZ, J., BREBOROWICZ,
Imatinib mesylate in Philadelphia chromosome-positive, chronic-
phase myeloid leukemia after failure of interferon alpha
(63 — 67)
E., TOTHOVA, A., KAFKOVA, M., FRICOVA, B., BENOVA, G., KIRSCHNEROVA, A., TOTHOVA,
In vitro sensitivity of leukemic cells to nucleoside derivatives
in childhood acute leukemias: good activity in leukemic relapses
(74 — 78)
J., STYCZYNSKI, M., WYSOCKI, R., DEBSKI, K., CZYZEWSKI, W., BALWIERZ, E., JURASZEWSKA, M., MATYSIAK, I., MALINOWSKA, E., STANCZAK, D., SONTA-JAKIMCZYK, T., SZCZEPANSKI, J., WACHOWIAK
Clinical results of intensity-modulated radiation therapy (IMRT)
for tumors of the head and neck region
(85 — 94)
K., ODRAZKA, J., PETERA, M., ZOUHAR, M., VOSMIK, M., VACULIKOVA, M., DOLEZEL, T., KOHLOVA, S., FILIP, J., CERAL, V., HOBZA, S., REHAK, J., DOLEZAL
The prognostic role of clinical, morphological and molecular
markers in oral squamous cell tumors
(95 — 102)
ZS., NEMETH, N., VELICH, S.,, M., UJPAL, G.,, ZS., SUBA,
CYP19 gene expression and aromatase activity in endometrial cancer
tissue: importance of the type of the disease
(115 — 118)
L., BERSTEIN, T., ZIMARINA, A., KOVALEVSKIJ, S., MAXIMOV, O., VOLKOV,
Peroxisome proliferator-activated receptors (PPAR) agonists affect
cell viability, apoptosis and expression of cell cycle related
proteins in cell lines of glial brain tumors
(126 — 136)
N., STRAKOVA, J., EHRMANN, J., BARTOS, J., MALIKOVA, J., DOLEZEL, Z., KOLAR,
Significance of qualitative PCR detection method for preemptive
therapy of cytomegalovirus infection in patiens after allogeneic
hematopoietic stem cell transplantation – single-centre experience
(137 — 142)
D., SKAPOVA, Z., RACIL, D., DVORAKOVA, D., MINARIKOVA, J., MAYER,
Cerebral metastases of malignant melanoma: contemporary treatment
modalities and survival outcome
(150 — 158)
I.E., PANAGIOTOU, E.N., BROUNTZOS, D.A., KELEKIS, M.A., PAPATHANASIOU, D.I., BAFALOUKOS,
Prevention of febrile neutropenia in cancer patients by probiotic
strain Enterococcus faecium M-74. Pilot study phase I
(159 — 164)
M., MEGO, L., EBRINGER, L., DRGONA, J., MARDIAK, J., TRUPL, R., GREKSAK, I., NEMOVA, E., ORAVCOVA, V., ZAJAC, I., KOZA,
Inoperable oropharyngeal carcinoma treated with concomitant
irradiation, mitomycin C and bleomycin – long term results
(165 — 174)
M., BUDIHNA, E., SOBA, L., SMID, B., ZAKOTNIK, P., STROJAN, M., CEMAZAR, I., FAJDIGA, M., ZARGI, A., ZUPEVC, H., LESNICAR,
The influence of thalidomide therapy on cytokine secretion,
immunophenotype, BCL-2 expression and microvessel density in
patients with resistant or relapsed multiple myeloma
(175 — 181)
A., DMOSZYNSKA, M., PODHORECKA, J., MANKO, A., BOJARSKA-JUNAK, J., ROLINSKI, D., SKOMRA,
Endostatin serum level in acute myeloid leukemia
(182 — 184)
T., WROBEL, G., MAZUR, K., KAPELKO, K., KULICZKOWSKI,
Estimation of taxol influence on changes in tubulin and vimentin
systems in K-562 and HL-60 cell lines by immunofluorescence
microscopy
(193 — 198)
A., GRZANKA, D., GRZANKA, M., ORLIKOWSKA, A., ZURYN, A., GRZANKA,
Prognostic significance of mitotic and apoptotic index and the DNA
cytometry in head and neck cancer
(199 — 207)
P., SMILEK, L., DUSEK, K., VESELY, J., ROTTENBERG, R., KOSTRICA,
Comparative analysis of thymidylate synthase, thymidine
phosphorylase and dihydropyrimidine dehydrogenase expression in
colorectal cancer and surrounding normal tissue
(208 — 210)
M., ZIMOVJANOVA, V., SYKORA, J., NOVOTNY, J., GATEK, L., PETRUZELKA, L., HOLUBEC, L., PECEN,
Modulation of BCRP mediated atypical multidrug resistance
phenotype by RNA interference
(219 — 224)
WT., LI, GY., ZHOU, XR., SONG, WL., CHI, RM., REN, XW., WANG,
Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers
(219 — 225)
J., SCHWARZ, D., MIKULENKOVA, M., CERMAKOVA, V., POLANSKA, K., MICHALOVA, I., MARINOV, V., CAMPR, Š., RANSDORFOVA, J., MARKOVA, L., PAVLISTOVA, J., BREZINOVA, J., SAJDOVA
Oridonin-induced apoptosis in leukemia K562 cells and its mechanism
(225 — 230)
J.J., LIU, R.W., HUANG, D.J., LIN, X.Y., WU, J., PENG, X.L., PAN, Y.Q., SONG, Q., LIN, M., HOU, D.N., WANG, F., CHEN, M.H., ZHANG
Allogeneic non-myeloablative hematopoietic stem cell
transplantation for treatment of metastatic renal cell carcinoma –
single center experience
(238 — 242)
P., RZEPECKI, J., ZOLNIEREK, T., SAROSIEK, P., LANGIEWICZ, C., SZCZYLIK,
Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line
treatment of germ cell tumors (GCT): a phase II study
(243 — 247)
J., MARDIAK, T., SALEK, Z., SYCOVA-MILA, J., OBERTOVA, Z., HLAVATA, M., MEGO, M., RECKOVA, I., KOZA,
Low mutational rate of K-ras codon 12 in singular bronchoscopy
specimens in suspected lung cancer
(255 — 259)
I., SPASOVA, H., NOVOTNA, J., VACHTENHEIM, H., BARTOSOVA, J., PATEK, V., HOSEROVA, P., ZATLOUKAL, Z., KINKOR,
Primary lymphoma of the liver – morphological and clinical analysis
of 6 cases. Success of aggressive treatment
(267 — 272)
B., ZIARKIEWICZ-WROBLEWSKA, B., GORNICKA, W., SULEIMAN, T., WROBLEWSKI, M., MORTON, G.M., WILCZYNSKI, H., HELENIAK, A., SKWAREK, L., KOPERSKI, K., DUDEK, M., KRAWCZYK, W.W., JEDRZEJCZAK
Flavonoid quercetin, but not apigenin or luteolin, induced
apoptosis in human myeloid leukemia cells and their resistant
variants
(273 — 279)
J., DURAJ, K., ZAZRIVCOVA, J., BODO, M., SULIKOVA, J., SEDLAK,
Lung cancer in relation to occupational and environmental chromium
exposure and smoking
(287 — 291)
E., HALASOVA, T., BASKA, F., KUKURA, D., MAZUROVA, E., BUKOVSKA, D., DOBROTA, I., POLIACEK, M., HALASA,
Pilot study of sole conformal peroperative interstitial
brachyradiotherapy of early stage breast carcinoma using high-dose
rate afterloading*
(292 — 296)
P., SLAMPA, R., SOUMAROVA, J., RUZICKOVA, V., CHRENKO, V., FAIT, R., BARTLOVA, H., TICHA, J., ZALOUDIK,
Soluble P-selectin concentration in patients with colorectal cancer
(297 — 301)
V., DYMICKA-PIEKARSKA, A., BUTKIEWICZ, J., MATOWICKA-KARNA, H., KEMONA,
Scintigraphy using 99mTc-MIBI (sestamibi), a sensitive parameter
of activity of multiple myeloma
(302 — 306)
J., BACOVSKY, V., SCUDLA, M., MYSLIVECEK, J., NEKULA, M., VYTRASOVA,
The relationship between antioxidant enzymes and bladder cancer
(314 — 317)
S., ARIKAN, T., AKCAY, D., KONUKOGLU, C., OBEK, A.R., KURAL,
Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute
leukemias
(318 — 324)
I., WOJCIK, M., SZYBKA, E., GOLANSKA, P., RIESKE, J.Z., BLONSKI, T., ROBAK, J., BARTKOWIAK,
Lack of STAT 1 phosphorylation at TYR 701 by IFN correlates with
disease outcome in melanoma patients
(330 — 337)
V., BOUDNY, L., DUSEK, L., ADAMKOVA, J., CHUMCHALOVA, I., KOCAK, V., FAIT, L., LAUEROVA, E., KREJCI, J., KOVARIK,
Tumor targeted gene therapy with plasmid expressing human tumor
necrosis factor alpha in vitro and in vivo
(344 — 351)
A., PASTORAKOVA, K., HLUBINOVA, J., BODO, J., LIBBY, B., RYCHLY, G., MARGISON, C., ALTANER,
Diazepam enhances hypericin-induced photocytotoxicity and apoptosis
in human glioblastoma cells
(352 — 359)
M., SARISSKY, J., LAVICKA, S., KOCANOVA, I., SULLA, A., MIROSSAY, P., MISKOVSKY, M., GAJDOS, J., MOJZIS, L., MIROSSAY,
Expression of the Insulin Receptor Substrate 1 in primary tumors and lymph
node metastases in breast cancer: correlations with Bcl-xL and Bax
proteins
(361 — 363)
M., KODA, M., SULKOWSKA, L., KANCZUGA-KODA, J., GOLASZEWSKA, W., KISIELEWSKI, M., BALTAZIAK, A., WINCEWICZ, S., SULKOWSKI,
MHC class I chain-related gene A (MICA) polymorphism and the
different
histological types of cervical cancer
(369 — 373)
J. R., CHEN, Y.J., LEE, T., CHEN, K.L., WANG, C.W., DANG, S.C., CHANG, H.F., LIU, Y. C., YANG,
Second primary tumors (SPT) of head and neck. Distinguishing of “true”
SPT from micrometastasis by LOH analysis of selected chromosome regions
(374 — 380)
M., GIEFING, M., RYDZANICZ, K., SZUKALA, A., WOZNIAK, M., WIERZBICKA, K., SZYFTER, M., KUJAWSKI,
A significance of additional chromosomal aberrations and other variables
on post transplantation outcome of patients with CML
(381 — 387)
V., VRANOVA, S., KATINA, G., KIRSCHNEROVA, M., MISTRIK, J., LAKOTA, J., HORAKOVA, A., TOTHOVA,
Pleural fluids associated with metastatic lung tumors are rich
in progelatinase B/proMMP-9
(388 — 392)
J., KOTYZA, M., PESEK, V., BEDNAROVA, M., TERL, B., WERLE,
Multivariate analyses of prognostic factors in acute myeloid
leukemia:
relevance of cytogenetic abnormalities and CD34 expression
(402 — 410)
C., JUNGHANSS, M., WAAK, A., KNOPP, H.D., KLEINE, G., KUNDT, M., LEITHAUSER, I., HILGENDORF, D., WOLFF, J., CASPER, M., FREUND,
Acute myeloid leukemia treatment in patients over 60 years of age. Comparison of symptomatic, palliative, and aggressive therapy
(411 — 414)
M., DOUBEK, I., PALASEK, Y., BRYCHTOVA, I., BUCHTOVA, J., MAYER,
Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization
(415 — 419)
J., BEDRNICEK, A., VICHA, M., JAROSOVA, M., HOLZEROVA, J., CINATL, JR, M., MICHAELIS, J., CINATL, T., ECKSCHLAGER,
The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia
(430 — 434)
J.M., HORACEK, R., PUDIL, M., TICHY, L., JEBAVY, A., STRASOVA, R., PRAUS, P., ZAK, J., MALY,
Cancer stem cells
(435 — 440)
A., SOLTYSOVA, V., ALTANEROVA, C., ALTANER,
High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies: do we really know why, when and how?
(456 — 463)
J., STERBA, D., VALIK, V., BAJCIOVA, V., KADLECOVA, V., GREGOROVA, D., MENDELOVA,
Expression of the P65 gene in gastric cancer and in tissues with or without Helicobacter pylori infection
(464 — 468)
E., BALCERCZAK, T., JANKOWSKI, A., BECHT, M., BALCERCZAK, R., JANIUK, D., JESIONEK-KUPNICKA, J., SZTOMPKA, M., MIROWSKI,
Predictors of local failure in early laryngeal cancer
(483 — 488)
R., LOHYNSKA, A., SLAVICEK, A., BAHANAN, P., NOVAKOVA,
The effect of doxorubicin on the expression of cyclin A in K-562 leukemia cell line
(489 — 493)
A., GRZANKA, A., ZURYN, J., STYCZYNSKI, A.A., GRZANKA, H., WISNIEWSKA,
Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study
(497 — 501)
J., MARDIAK, T., SALEK, Z., SYCOVA-MILA, J., OBERTOVA, Z., HLAVATA, M., MEGO, M., RECKOVA, I., KOZA,
